Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (551-560 of 790) with videos related to

Pageof 79
Sort By:
Expert Reviews in Molecular Medicine|September 1, 2006
Tryptophan metabolism in the central nervous system: medical implicationsJon P Ruddick, Andrew K Evans, David J Nutt, et al.
Human Psychopharmacology|October 3, 2012
The effect of a clinically effective and non-effective dose of lorazepam on 7.5% CO₂-induced anxietyAlison Diaper, Andreas Papadopoulos, Ann S Rich, et al.
Journal of Affective Disorders|February 7, 2018
Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depressionFacundo Carrillo, Mariano Sigman, Diego Fernández Slezak, et al.
Annals of Neurology|October 24, 1997
Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypesS Zareparsi, J Kaye, R Camicioli, et al.
Bjpsych Open|January 20, 2022
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic reviewZach Walsh, Ozden Merve Mollaahmetoglu, Joseph Rootman, et al.
British Medical Bulletin|April 17, 2003
AddictionA R Lingford-Hughes, S J C Davies, S McIver, et al.
American Journal of Human Genetics|October 1, 1994
A gene for episodic ataxia/myokymia maps to chromosome 12p13M Litt, P Kramer, D Browne, et al.
Bjpsych Open|January 18, 2022
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review - CORRIGENDUMZach Walsh, Ozden Merve Mollaahmetoglu, Joseph Rootman, et al.
Pharmacological Reviews|September 26, 2015
Mechanisms of Action and Persistent Neuroplasticity by Drugs of AbuseEsa R Korpi, Bjørnar den Hollander, Usman Farooq, et al.
CNS Spectrums|February 10, 2004
WCA Recommendations for the long-term treatment of posttraumatic stress disorderDan J Stein, Borwin Bandelow, Eric Hollander, et al.
Pageof 79

Showing results (551-560 of 790) with videos related to

Sort By:
Pageof 79
Expert Reviews in Molecular Medicine|September 1, 2006
Tryptophan metabolism in the central nervous system: medical implicationsJon P Ruddick, Andrew K Evans, David J Nutt, et al.
Human Psychopharmacology|October 3, 2012
The effect of a clinically effective and non-effective dose of lorazepam on 7.5% CO₂-induced anxietyAlison Diaper, Andreas Papadopoulos, Ann S Rich, et al.
Journal of Affective Disorders|February 7, 2018
Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depressionFacundo Carrillo, Mariano Sigman, Diego Fernández Slezak, et al.
Annals of Neurology|October 24, 1997
Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypesS Zareparsi, J Kaye, R Camicioli, et al.
Bjpsych Open|January 20, 2022
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic reviewZach Walsh, Ozden Merve Mollaahmetoglu, Joseph Rootman, et al.
British Medical Bulletin|April 17, 2003
AddictionA R Lingford-Hughes, S J C Davies, S McIver, et al.
American Journal of Human Genetics|October 1, 1994
A gene for episodic ataxia/myokymia maps to chromosome 12p13M Litt, P Kramer, D Browne, et al.
Bjpsych Open|January 18, 2022
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review - CORRIGENDUMZach Walsh, Ozden Merve Mollaahmetoglu, Joseph Rootman, et al.
Pharmacological Reviews|September 26, 2015
Mechanisms of Action and Persistent Neuroplasticity by Drugs of AbuseEsa R Korpi, Bjørnar den Hollander, Usman Farooq, et al.
CNS Spectrums|February 10, 2004
WCA Recommendations for the long-term treatment of posttraumatic stress disorderDan J Stein, Borwin Bandelow, Eric Hollander, et al.
Pageof 79